News & Analysis as of August 25, 2025

Drug Pricing

+ Follow

The Patient Protection and Affordable Care Act (PPAC), also known as Obamacare, is a United States federal statute passed in March of 2010. The Act creates a nationwide insurance system and provides federal... more +

Holland & Knight Health Dose: July 29, 2025

Holland & Knight LLP on 7/30/2025

This week, the U.S. House of Representatives will be out of session, as the chamber has adjourned for the August 2025 district work period. The U.S. Senate remains in session and continues to consider nominations to lead...more

The Trifecta: What to Expect from a Second Trump Administration and a Republican Congress

King & Spalding on 12/11/2024

Republicans have swept the 2024 elections, returning Donald Trump to the White House as the 47th President and flipping the Senate to a Republican majority. Having narrowly maintained control of the House of Representatives,...more

Trump Administration: 2017 Recap and 2018 Outlook

Akin Gump Strauss Hauer & Feld LLP on 1/17/2018

On January 20, 2017, businessman Donald J. Trump was sworn in as the 45th President of the United States following a contentious and unconventional 2016 presidential election. Republicans also successfully maintained control...more

Health Care Update - February 2016 #2

Mintz - ML Strategies on 2/16/2016

Martin Shkreli Not the Big Story on the Hill Last Week - Congress’s complex relationship with prescription drugs was on display last week in the House of Representatives. In the House Committee on Oversight and...more

Congressional Oversight in the 114th Congress: What to Expect in 2016

King & Spalding on 1/26/2016

While it is likely that the Obama Administration will continue to be a major focus of GOP-led oversight inquiries in 2016, industry stakeholders, particularly those affected by legislation or proposed regulations, should also...more

Health Care Update - December 2015

Mintz - ML Strategies on 12/9/2015

Cadillac Tax Repeal Garners Bipartisan Support; Prospects for Implementation Delay Increase - Last week, the Senate passed its reconciliation package by a vote of 52-47, sending it back to the House for approval and...more

Health Care Update - November 2015 #2

Mintz - ML Strategies on 11/18/2015

FDA Hosts Genome Scientists For Next-Generation Sequencing Conference - Last week, the Food and Drug Administration (FDA) hosted genome scientists from across the nation at its campus in White Oak, Maryland. Two public...more

Health Care Update - November 2015

Mintz - ML Strategies on 11/4/2015

Ways & Means Leadership Changes – Health Policy Implications Looming: As Congress pushes forward with a two-year budget deal, and new Speaker Paul Ryan begins his tenure as the top Republican in the House of...more

Health Care Update - October 2015

Mintz - ML Strategies on 10/29/2015

Senate Working Group Pressing Forward on Telehealth - As Congress focuses on bigger picture policy decisions, including broad budget negotiations and raising the debt ceiling, there are some exciting developments on the...more

Does Invalidation of 340B Orphan Drug Rule Doom HRSA’s Guidance?

Mintz - Health Care Viewpoints on 10/21/2015

Our recent post on HRSA’s Omnibus Proposed Guidance for the 340B Drug Discount Program (Proposed Guidance) noted that since the DC District Court had yet to rule on the validity of HRSA’s “interpretive” 340B orphan drug rule,...more

Health Care Update - July 2015 #2

Mintz - ML Strategies on 7/21/2015

Congress Slowly Works on Budget Reconciliation; ACA Reform Proposals Still Up in the Air - The FY 2016 budget resolution, which was agreed to by Congress this past April, included broad reconciliation instructions...more

11 Results

View per page

Page: of 1

Patient Protection and Affordable Care Act (PPACA) › Congressional Investigations & Hearings › Drug Pricing

"My best business intelligence, in one easy email…"